Literature DB >> 9792223

Effect of Vernonia cinerea Less flower extract in adjuvant-induced arthritis.

R M Latha1, T Geetha, P Varalakshmi.   

Abstract

1. The anti-inflammatory effect of an alcoholic extract from the flower of Vernonia cinerea (Asteraceae; Less) was tested in adjuvant arthritic rats. 2. Changes in paw volume, body and tissue weights and serum and tissue enzyme activities of ALT, AST, ACP and cathepsin-D in adjuvant rats were reversed by oral administration of 100 mg/kg body weight (BW) of the flower extract. 3. The extract also reversed the major histopathological changes in the hindpaws of the arthritic rats. 4. Phytochemical studies revealed the presence of alkaloids, saponins, steroids and flavonoids. 5. It is concluded that the extract contains as yet unidentified anti-inflammatory principle(s).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792223     DOI: 10.1016/s0306-3623(98)00049-4

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  20 in total

1.  Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice.

Authors:  P Pratheeshkumar; Girija Kuttan
Journal:  Inflammopharmacology       Date:  2010-05-15       Impact factor: 4.473

2.  Enhancement of the anti-inflammatory and anti-arthritic effects of theophylline by a low dose of a nitric oxide donor or non-specific nitric oxide synthase inhibitor.

Authors:  Adel Gomaa; Mohsen Elshenawy; Noha Afifi; Eman Mohammed; Romany Thabit
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  Bioactivity-guided isolation of cytotoxic sesquiterpenes of Rolandra fruticosa.

Authors:  Li Pan; Daniel D Lantvit; Soedarsono Riswan; Leonardus B S Kardono; Hee-Byung Chai; Esperanza J Carcache de Blanco; Norman R Farnsworth; Djaja Doel Soejarto; Steven M Swanson; A Douglas Kinghorn
Journal:  Phytochemistry       Date:  2010-02-25       Impact factor: 4.072

5.  A simple and efficient method for agroinfection of Vernonia cinerea with infectious clones of Vernonia yellow vein virus.

Authors:  R M Packialakshmi; R Usha
Journal:  Virus Genes       Date:  2011-08-18       Impact factor: 2.332

6.  Antimicrobial and Antioxidant Potential of Vernonia Cinerea Extract Coated AuNPs.

Authors:  Lalita Singh; Reena Antil; Pushpa Dahiya
Journal:  Indian J Microbiol       Date:  2021-09-07       Impact factor: 2.461

7.  Vernonia cinerea Less. supplementation and strenuous exercise reduce smoking rate: relation to oxidative stress status and beta-endorphin release in active smokers.

Authors:  Donrawee Leelarungrayub; Sainatee Pratanaphon; Prapas Pothongsunun; Thanyaluck Sriboonreung; Araya Yankai; Richard J Bloomer
Journal:  J Int Soc Sports Nutr       Date:  2010-05-26       Impact factor: 5.150

8.  Effect and mechanism of AR-6 in experimental rheumatoid arthritis.

Authors:  Shi-xue Sun; Yun-man Li; Wei-rong Fang; Peng Cheng; Lifang Liu; Fengwen Li
Journal:  Clin Exp Med       Date:  2009-10-20       Impact factor: 3.984

9.  Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.

Authors:  Shweta Pandey; Vijay Kumar; Ankita Leekha; Nishant Rai; Farhan Jalees Ahmad; Anita Kamra Verma; Sushama Talegaonkar
Journal:  Pharm Res       Date:  2018-09-05       Impact factor: 4.200

10.  Therapeutic Potential of Polar and Non-Polar Extracts of Cyanthillium cinereum In Vitro.

Authors:  Gunjan Guha; V Rajkumar; R Ashok Kumar; Lazar Mathew
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.